ClinicalTrials.govpublic full text
Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD
atherosclerotic cardiovascular disease (ascvd), lipoprotein(a), cardiovascular disease, ascvd, pelacarsen (tqj230), interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 853699
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.